Cargando…

Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report

RATIONALE: Glucagonoma is an uncommon disease but it has been associated with a pattern of symptoms defined as glucagonoma syndrome. These symptoms, if promptly recognized, could help to speed up the diagnosing process. PATIENT CONCERNS: We report a case of a 68-year-old woman with a pancreatic gluc...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrias, Giuseppe, Horvat, Natally, Monti, Serena, Basturk, Olca, Lin, Oscar, Saba, Luca, Bodei, Lisa, Reidy, Diane L., Mannelli, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815774/
https://www.ncbi.nlm.nih.gov/pubmed/29390362
http://dx.doi.org/10.1097/MD.0000000000009252
_version_ 1783300566735126528
author Corrias, Giuseppe
Horvat, Natally
Monti, Serena
Basturk, Olca
Lin, Oscar
Saba, Luca
Bodei, Lisa
Reidy, Diane L.
Mannelli, Lorenzo
author_facet Corrias, Giuseppe
Horvat, Natally
Monti, Serena
Basturk, Olca
Lin, Oscar
Saba, Luca
Bodei, Lisa
Reidy, Diane L.
Mannelli, Lorenzo
author_sort Corrias, Giuseppe
collection PubMed
description RATIONALE: Glucagonoma is an uncommon disease but it has been associated with a pattern of symptoms defined as glucagonoma syndrome. These symptoms, if promptly recognized, could help to speed up the diagnosing process. PATIENT CONCERNS: We report a case of a 68-year-old woman with a pancreatic glucagonoma. Her symptoms at the onset were typical of the glucagonoma syndrome. DIAGNOSES: After a significant weight loss, she underwent a computer tomography scan of the abdomen, which showed a hypervascular lesion of the tail of the pancreas and hypervascular lesions of the liver. An ultrasound guided biopsy was performed and pathology was consistent with glucagonoma. Her blood glucagon levels were elevated. OUTCOMES: She was treated with chemotherapy and somatostatin analogs. After 4 years, the disease had a malignant transformation, and metastases suddenly started to grow up. She stopped being responsive to treatment and eventually passed away. LESSONS: Due to its rarity, clinical diagnosis is challenging and generally it comes after a long interval since the onset of symptoms. Awareness of physicians and dermatologists of the characteristic necrolytic migratory erythema, and of the other symptoms, often leads to early diagnosis.
format Online
Article
Text
id pubmed-5815774
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-58157742018-02-28 Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report Corrias, Giuseppe Horvat, Natally Monti, Serena Basturk, Olca Lin, Oscar Saba, Luca Bodei, Lisa Reidy, Diane L. Mannelli, Lorenzo Medicine (Baltimore) 6800 RATIONALE: Glucagonoma is an uncommon disease but it has been associated with a pattern of symptoms defined as glucagonoma syndrome. These symptoms, if promptly recognized, could help to speed up the diagnosing process. PATIENT CONCERNS: We report a case of a 68-year-old woman with a pancreatic glucagonoma. Her symptoms at the onset were typical of the glucagonoma syndrome. DIAGNOSES: After a significant weight loss, she underwent a computer tomography scan of the abdomen, which showed a hypervascular lesion of the tail of the pancreas and hypervascular lesions of the liver. An ultrasound guided biopsy was performed and pathology was consistent with glucagonoma. Her blood glucagon levels were elevated. OUTCOMES: She was treated with chemotherapy and somatostatin analogs. After 4 years, the disease had a malignant transformation, and metastases suddenly started to grow up. She stopped being responsive to treatment and eventually passed away. LESSONS: Due to its rarity, clinical diagnosis is challenging and generally it comes after a long interval since the onset of symptoms. Awareness of physicians and dermatologists of the characteristic necrolytic migratory erythema, and of the other symptoms, often leads to early diagnosis. Wolters Kluwer Health 2017-12-15 /pmc/articles/PMC5815774/ /pubmed/29390362 http://dx.doi.org/10.1097/MD.0000000000009252 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 6800
Corrias, Giuseppe
Horvat, Natally
Monti, Serena
Basturk, Olca
Lin, Oscar
Saba, Luca
Bodei, Lisa
Reidy, Diane L.
Mannelli, Lorenzo
Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report
title Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report
title_full Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report
title_fullStr Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report
title_full_unstemmed Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report
title_short Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report
title_sort malignant transformation of glucagonoma with spect/ct in-111 octreoscan features: a case report
topic 6800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815774/
https://www.ncbi.nlm.nih.gov/pubmed/29390362
http://dx.doi.org/10.1097/MD.0000000000009252
work_keys_str_mv AT corriasgiuseppe malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport
AT horvatnatally malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport
AT montiserena malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport
AT basturkolca malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport
AT linoscar malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport
AT sabaluca malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport
AT bodeilisa malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport
AT reidydianel malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport
AT mannellilorenzo malignanttransformationofglucagonomawithspectctin111octreoscanfeaturesacasereport